The Europe Artificial Intelligence (AI) in Healthcare Market would witness market growth of 40.8% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Artificial Intelligence (AI) in Healthcare Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $15,019.9 million by 2031. The UK market is exhibiting a CAGR of 39.6% during (2024 - 2031). Additionally, The France market would experience a CAGR of 41.9% during (2024 - 2031).
Genomic data can be analyzed by AI algorithms to detect genetic markers that are related to diseases or drug responses. This information helps healthcare providers to tailor treatment programs to individual patients based on their genetic makeup, thereby increasing therapy efficacy, and reducing adverse reactions. AI-powered platforms can analyze tumor genomics and patient data to guide treatment decisions in oncology. By matching patients with targeted therapies based on their molecular profiles, precision oncology aims to improve patient outcomes and reduce the reliance on one-size-fits-all treatments like chemotherapy.
AI models can analyze electronic health records (EHRs), medical histories, and real-time patient data to predict disease progression, identify at-risk patients, and recommend personalized treatment plans. Predictive analytics tools assist clinicians in making informed decisions and prioritizing interventions for high-risk patients. AI-powered NLP algorithms can extract insights from unstructured clinical notes, research articles, and other textual data sources. NLP enables healthcare providers to access and analyze vast medical literature and patient records, supporting evidence-based decision-making and research.
The aging population in the UK presents diverse healthcare needs, requiring personalized care plans tailored to individual patient characteristics and preferences. AI-powered assistive technologies, such as smart home devices, wearable sensors, and cognitive assistance tools, can enhance the independence and quality of life of older adults in the UK. AI-driven remote monitoring and telehealth solutions are gaining prominence in the UK for managing the health of older adults in their homes. These technologies enable remote monitoring of vital signs, medication adherence, and lifestyle behaviors, while AI algorithms analyze the data to detect deviations from normal patterns and provide timely interventions or alerts to healthcare providers in UK. As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The proportion of the working-age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on Offering, the market is segmented into Software, Hardware (Processors, Memory, and Network), and Services. Based on Software Platform, the market is segmented into Application Program Interface (API), and Machine Learning Framework. Based on Software Solution, the market is segmented into On-premise, and Cloud. Based on Technology, the market is segmented into Machine Learning, Natural Language Processing, Context-aware Computing, and Computer Vision. Based on End-use, the market is segmented into Healthcare Providers, Healthcare Companies, Healthcare Payers, Patients, and Others. Based on Application, the market is segmented into Patient Data & Risk Analysis, Virtual Assistants, Wearables, Medical Imaging & Diagnostics, Cybersecurity, Mental Health, In-Patient Care & Hospital Management, Precision Medicine, Drug Discovery & Development, Lifestyle Management & Remote Patient Monitoring, Healthcare Assistance Robots, Research, Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Artificial Intelligence (AI) in Healthcare Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $15,019.9 million by 2031. The UK market is exhibiting a CAGR of 39.6% during (2024 - 2031). Additionally, The France market would experience a CAGR of 41.9% during (2024 - 2031).
Genomic data can be analyzed by AI algorithms to detect genetic markers that are related to diseases or drug responses. This information helps healthcare providers to tailor treatment programs to individual patients based on their genetic makeup, thereby increasing therapy efficacy, and reducing adverse reactions. AI-powered platforms can analyze tumor genomics and patient data to guide treatment decisions in oncology. By matching patients with targeted therapies based on their molecular profiles, precision oncology aims to improve patient outcomes and reduce the reliance on one-size-fits-all treatments like chemotherapy.
AI models can analyze electronic health records (EHRs), medical histories, and real-time patient data to predict disease progression, identify at-risk patients, and recommend personalized treatment plans. Predictive analytics tools assist clinicians in making informed decisions and prioritizing interventions for high-risk patients. AI-powered NLP algorithms can extract insights from unstructured clinical notes, research articles, and other textual data sources. NLP enables healthcare providers to access and analyze vast medical literature and patient records, supporting evidence-based decision-making and research.
The aging population in the UK presents diverse healthcare needs, requiring personalized care plans tailored to individual patient characteristics and preferences. AI-powered assistive technologies, such as smart home devices, wearable sensors, and cognitive assistance tools, can enhance the independence and quality of life of older adults in the UK. AI-driven remote monitoring and telehealth solutions are gaining prominence in the UK for managing the health of older adults in their homes. These technologies enable remote monitoring of vital signs, medication adherence, and lifestyle behaviors, while AI algorithms analyze the data to detect deviations from normal patterns and provide timely interventions or alerts to healthcare providers in UK. As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The proportion of the working-age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on Offering, the market is segmented into Software, Hardware (Processors, Memory, and Network), and Services. Based on Software Platform, the market is segmented into Application Program Interface (API), and Machine Learning Framework. Based on Software Solution, the market is segmented into On-premise, and Cloud. Based on Technology, the market is segmented into Machine Learning, Natural Language Processing, Context-aware Computing, and Computer Vision. Based on End-use, the market is segmented into Healthcare Providers, Healthcare Companies, Healthcare Payers, Patients, and Others. Based on Application, the market is segmented into Patient Data & Risk Analysis, Virtual Assistants, Wearables, Medical Imaging & Diagnostics, Cybersecurity, Mental Health, In-Patient Care & Hospital Management, Precision Medicine, Drug Discovery & Development, Lifestyle Management & Remote Patient Monitoring, Healthcare Assistance Robots, Research, Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Koninklijke Philips N.V.
- Microsoft Corporation
- Siemens Healthineers AG (Siemens AG)
- Intel Corporation
- NVIDIA Corporation
- Google LLC (Alphabet Inc.)
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- Amazon Web Services, Inc. (Amazon.com, Inc.)
- Oracle Corporation
Market Report Segmentation
By Offering- Software
- Software Platform
- Application Program Interface (API)
- Machine Learning Framework
- Software Solution
- On-premise
- Cloud
- Hardware
- Processors
- Memory
- Network
- Services
- Machine Learning
- Natural Language Processing
- Context-aware Computing
- Computer Vision
- Healthcare Providers
- Healthcare Companies
- Healthcare Payers
- Patients
- Others
- Patient Data & Risk Analysis
- Virtual Assistants
- Wearables
- Medical Imaging & Diagnostics
- Cybersecurity
- Mental Health
- In-Patient Care & Hospital Management
- Precision Medicine
- Drug Discovery & Development
- Lifestyle Management & Remote Patient Monitoring
- Healthcare Assistance Robots
- Research
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Europe Artificial Intelligence (AI) in Healthcare Market by Offering
Chapter 6. Europe Artificial Intelligence (AI) in Healthcare Market by Technology
Chapter 7. Europe Artificial Intelligence (AI) in Healthcare Market by End-use
Chapter 8. Europe Artificial Intelligence (AI) in Healthcare Market by Application
Chapter 9. Europe Artificial Intelligence (AI) in Healthcare Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Koninklijke Philips N.V.
- Microsoft Corporation
- Siemens Healthineers AG (Siemens AG)
- Intel Corporation
- NVIDIA Corporation
- Google LLC (Alphabet Inc.)
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- Amazon Web Services, Inc. (Amazon.com, Inc.)
- Oracle Corporation
Methodology
LOADING...
